Astec LifeSciences Limited

NSE ASTEC.NS

Astec LifeSciences Limited Debt to Equity Ratio for the year ending March 31, 2024: 1.34

Astec LifeSciences Limited Debt to Equity Ratio is 1.34 for the year ending March 31, 2024, a 64.39% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Astec LifeSciences Limited Debt to Equity Ratio for the year ending March 31, 2023 was 0.81, a 15.46% change year over year.
  • Astec LifeSciences Limited Debt to Equity Ratio for the year ending March 31, 2022 was 0.70, a 16.37% change year over year.
  • Astec LifeSciences Limited Debt to Equity Ratio for the year ending March 31, 2021 was 0.61, a 51.24% change year over year.
  • Astec LifeSciences Limited Debt to Equity Ratio for the year ending March 31, 2020 was 0.40, a -53.85% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
NSE: ASTEC.NS

Astec LifeSciences Limited

CEO Ms. Tejashree Rohan Pradhan
IPO Date Nov. 25, 2009
Location India
Headquarters Godrej One
Employees 606
Sector Health Care
Industries
Description

Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

Similar companies

BALAMINES.NS

Balaji Amines Limited

USD 19.80

0.45%

DHANUKA.NS

Dhanuka Agritech Limited

USD 15.72

3.16%

NEULANDLAB.NS

Neuland Laboratories Limited

USD 153.69

1.58%

SUDARSCHEM.NS

Sudarshan Chemical Industries Limited

USD 12.66

2.02%

BHARATRAS.NS

Bharat Rasayan Limited

USD 110.20

2.04%

StockViz Staff

January 15, 2025

Any question? Send us an email